Jeevan Scientific Technology Ltd receives CDSCO nod for increase in bed capacity

Central Drugs Standard Control Organization (CDSCO) has granted approval for the increase in the bed capacity from 132 and 06 ICU beds to 156 and 08 ICU beds of Jeevan Scientific Technology Limited's existing approved Bioavailability/Bioequivalence (BA/BE) Study Centre situated at Plot No. B-17, TIE Phase 1I, Balanagar, Hyderabad - 500037, Telangana, India.

The approval has been granted pursuant to the successful completion of the regulatory inspection conducted by the CDSCO on June 24, 2026 and the Company's application seeking enhancement of the bed capacity at the said BA/BE Study Centre.

The increased bed capacity will strengthen the Company's clinical research infrastructure, enhance its operational capabilities, and enable it to undertake a higher volume of Bioavailability/Bioequivalence studies, thereby supporting future business growth.

The Company remains committed to maintaining the highest standards of quality, regulatory compliance, and patient safety in all its clinical research operations.

Shares of Jeevan Scientific Technology Ltd was last trading in BSE at Rs. 71.40 as compared to the previous close of Rs. 72.52. The total number of shares traded during the day was 7280 in over 80 trades.

The stock hit an intraday high of Rs. 73.69 and intraday low of 71.00. The net turnover during the day was Rs. 526822.00.

Source : Equity Bulls

Keywords

JeevanScientificTechnology INE237B01018 HealthcareServices CDSCOApproval